ArticleEFSA journal. European Food Safety Authority2017
Modification of the existing maximum residue levels for difenoconazole in various crops.
Article in EFSA journal. European Food Safety Authority, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 13 citations in OpenAlex.
- Setting of import tolerances for difenoconazole in various crops.EFSA journal. European Food Safety Authority · 2025Article
- Review of the existing maximum residue levels for difenoconazole according to Article 12 of Regulation (EC) No 396/2005.EFSA journal. European Food Safety Authority · 2024Article
- Scientific support for preparing an EU position in the 55th Session of the Codex Committee on Pesticide Residues (CCPR).EFSA journal. European Food Safety Authority · 2024Article
- Modification of the existing maximum residue levels for difenoconazole in wheat and rye.EFSA journal. European Food Safety Authority · 2023Article
- Scientific support for preparing an EU position in the 54th Session of the Codex Committee on Pesticide Residues (CCPR).EFSA journal. European Food Safety Authority · 2023Article
- Modification of the existing maximum residue levels for difenoconazole in leafy brassica.EFSA journal. European Food Safety Authority · 2021Article
- Scientific support for preparing an EU position in the 50th Session of the Codex Committee on Pesticide Residues (CCPR).EFSA journal. European Food Safety Authority · 2018Article
- Modification of the existing maximum residue levels for difenoconazole in various crops.EFSA journal. European Food Safety Authority · 2018Article
- Modification of the existing maximum residue levels for difenoconazole in various crops.EFSA journal. European Food Safety Authority · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In accordance with Article 6 of Regulation (EC) No 396/2005, the evaluating Member States (EMS), Greece and Austria, received applications from Syngenta and Adama, respectively, to modify the existing maximum residue levels (MRLs) for the active substance difenoconazole in various crops and barley, respectively. The data submitted in support of the requests were found to be sufficient to derive MRL proposals for all crops under consideration. Adequate analytical methods for enforcement are available to control the residues of difenoconazole on the commodities under consideration. Based on the risk assessment results, EFSA concludes that the proposed uses of difenoconazole on the commodities under consideration will not result in a consumer exposure exceeding the toxicological reference values for the active substance and therefore are unlikely to pose a consumer health risk, except for the indoor use on scaroles. An acute consumer risk cannot be excluded for this use and a lower MRL is proposed based on the outdoor uses only.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.